Free Republic

Sen. Joe Manchin (D-WV) reportedly remains interested in launching a 2024 presidential bid on a “No Labels” ticket if President Joe Biden, 81, has a “health scare.” If he enters the race, Manchin would siphon votes from Biden, potentially dooming the president’s reelection campaign. Democrats have raised concerns for months about Biden’s 2024 chances due to poor polling about his age and physical stamina: Redfield & Wilton Strategies: A majority of Democrats are “concerned” about Biden’s ability. YouGov: Fifty-five percent say Biden’s health and age “severely” limit his ability to do the job. NBC News: Most registered voters have “major”...

Sen. Joe Manchin (D-W.V.) has privately warned the White House and congressional leaders that he has specific policy concerns with President Biden's $3.5 trillion social spending dream — and he'll support as little as $1 trillion of it — Axios' Hans Nichols scoops. At most, he's open to supporting $1.5 trillion, sources familiar with the discussions say. Why it matters: In a 50-50 Senate, that could mean the ceiling for Biden's "Build Back Better" agenda — and that many progressive priorities, from universal preschool to free community college, are in danger of dying this Congress. Manchin also has committed to...

HEATHER BRESCH, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new documents released as part of an ongoing lawsuit.The documents also show Bresch approving a scheme to force customers, captured by the company’s monopoly, to purchase two EpiPens at once, regardless of medical need. The EpiPen is an auto-injectable device that injects epinephrine into the body and can be the difference between life or death for a person suffering a severe allergic reaction.The documents were released as part of an...

Pelosi dismisses Manchin call for 'pause' on $3.5T spending plan © Greg Nash House Speaker Nancy Pelosi dismissed Sen. Joe Manchin’s (D-W.Va.) call for a “pause” in deliberations on the $3.5 trillion spending package, saying she does not agree with the moderate senator’s recommendation. Pelosi, when on Monday for her reaction to Manchin’s call for a pause, said “Well obviously I don’t agree.” “I'm pretty excited about where we are. Everybody's working very hard, the committee's are doing their work. We’re on a good timetable, and I feel very exhilarated by it,” she added.

Makers of the EpiPen auto-injector said they would offer a 50 percent discount after public outrage over a 500-percent price hike. Hillary Clinton was among those calling for the price reduction – and her supporters were quick to give her all the credit. EpiPen administers a quick dose of epinephrine to counter a severe, life-threatening allergic reaction known as anaphylaxis. The easy-to-use injector is made by West Virginia-based Mylan Pharmaceuticals, which bought the rights to it in 2007. Since then, the price of the EpiPen has skyrocketed, going from $100 to $600. On Thursday, Reuters seemed to give Clinton the...

West Virginia Democrat Sen. Joe Manchin’s daughter, Mylan CEO Heather Bresch, who has come under fire for her company’s widely-slammed decision to raise the cost of the EpiPen by 461 Percent since 2007, raised her salary by a whopping 671 percent during her tenure at the pharmaceutical giant. Bresch’s annual income jumped from $2,453,456 in 2007 to $18,931,068 in 2015, coinciding with the astounding price increase on the life-saving emergency allergy shot, The Chicago Tribune reports. In addition to her astoundingly high salary, Bresch reportedly took advantage of a number of unprecedented perks, including personal use of the company’s aircraft....

CEO who gouged price of EpiPen is daughter of Democrat senator CHARLESTON, W.Va. — As a pharmaceutical company run by U.S. Sen. Joe Manchin’s daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum. The Democratic West Virginia senator’s daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens. A two-dose package cost around $94 nine years ago. The cost averaged more than six times that in May. Manchin spokesman Jonathan Kott said Wednesday the senator had no comment.